Stevanato Group S.p.A STVN
NYSE STVN
$15.80 +1.49 (+10.41%)
At close: Nov 13, 2026 · 4:00 PM EST

Stevanato Group S.p.A (STVN) Return on Equity [ROE] (2021 - 2026)

Updated

Stevanato Group S.p.A's Return on Equity [ROE] came in at 9.11% for the quarter ended Sep 30, 2026, down 0.23 percentage points from 9.34% a year earlier but up 0.20 percentage points from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Stevanato Group S.p.A's Return on Equity [ROE] was 9.85%, up 0.46 percentage points from the prior year.

  • Return on Equity [ROE] carries a five-year change of -16.59 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Return on Equity [ROE] was 9.39% in the year ended Dec 31, 2024 (-4.22 pp), 13.61% in the year ended Dec 31, 2023 (-1.35 pp), 14.96% in the year ended Dec 31, 2022 (-8.85 pp) and 23.81% in the year ended Dec 31, 2021 (-2.63 pp).
  • The five-year range for quarterly Return on Equity [ROE] is 8.58% (the quarter ended Sep 30, 2024) to 16.95% (the quarter ended Dec 31, 2021).
  • Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -0.66 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in the quarter ended Sep 30, 2025 (a gain of 0.76 percentage points), and the weakest in the quarter ended Sep 30, 2022 (a drop of 5.67 percentage points).
  • Business Quant data shows STVN's Return on Equity [ROE] at 8.91% (quarter ended Jun 30, 2026), 9.37% (quarter ended Mar 31, 2026) and 9.27% (quarter ended Dec 31, 2025) in the three quarters before the quarter ended Sep 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 9.09%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 17.28%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 17.46%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 9.36%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 4.56%
10 Stevanato Group S.p.A 4.78 Bn 4.32 Bn 109.24 Mn 9.11%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.11%
Jun 30, 2026 8.91%
Mar 31, 2026 9.37%
Dec 31, 2025 9.27%
Sep 30, 2025 9.34%
Jun 30, 2025 9.21%
Mar 31, 2025 9.00%
Dec 31, 2024 8.66%
Sep 30, 2024 8.58%
Jun 30, 2024 9.29%
Mar 31, 2024 10.98%
Dec 31, 2023 13.07%
Sep 30, 2023 13.74%
Jun 30, 2023 13.53%
Mar 31, 2023 13.63%
Dec 31, 2022 14.91%
Sep 30, 2022 15.92%
Jun 30, 2022 14.09%
Mar 31, 2022 15.01%
Dec 31, 2021 16.95%
API Access

Stevanato Group S.p.A Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=STVN&period=max&api_key=YOUR_API_KEY